With a $400M Deal: Ideaya Targets Biocytogens BsADC Program
For an option on Biocytogen Pharmaceuticals’ possible first-in-class B7H3/PTK7 BsADC program, Ideaya Biosciences is paying more than $400 million. The goal of antibody drug conjugates (ADCs) is to give highly focused therapy by combining the cytotoxic medicines with the specificity of monoclonal antibodies. According to Biocytogen, B7H3/PTK7 is co-expressed in a variety of solid tumor […]
Touchlight, University of Nottingham Partner to Develop Zika DNA Vaccine
Scientists at the University of Nottingham are scaling up the development of a new Zika virus DNA vaccine thanks to a collaboration with specialist company, Touchlight, who will provide new technology to to produce large quantities of the DNA vaccine at speed. Touchlight, an innovation-driven contract development and manufacturing organization (CDMO) specializing in enzymatic DNA […]
RedHill announces launch of Talicia in UAE to treat bacterial infection
RedHill Biopharma Ltd. , a specialty biopharmaceutical company announced the launch of Talicia (omeprazole magnesium, amoxicillin and rifabutin) in the United Arab Emirates (UAE) – making it available by prescription to treat adults with Helicobacter pylori (H. pylori) infection. The commercial launch of Talicia in the UAE triggers RedHill’s eligibility for additional potential milestone payments, […]
PCI Pharma Services’ Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection
PCI is the first CDMO to undergo ICMRA’s inspection pilot program. PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), has successfully completed the International Coalition of Medicines Regulatory Authorities (ICMRA) inspection of its Bedford, New Hampshire campus. In doing so, PCI becomes the first drug product CDMO to navigate the […]
QIAGEN and Parkway Laboratories partner to enhance healthcare services in Singapore with QIAstat-Dx syndromic testing
Collaboration to improve patient care and epidemiological monitoring in Parkway Group’s private hospitals QIAstat-Dx syndromic testing to provide quick and accurate detection of respiratory, gastrointestinal and central nervous system infections Partnership aims to reduce the burden on healthcare systems, leading to effective public health management QIAGEN Singapore Pte. Ltd. today announced a partnership with […]
Turkish Cargo Receives the IATA Smart Facility Operational Capacity Certification for its SMARTIST Facility at Istanbul Airport
Turkish Cargo, the air cargo brand of Turkish Airlines, has received the IATA Smart Facility Operational Capacity Certification. This prestigious certification, received for the SMARTIST Terminal, confirms that Turkish Cargo’s operational procedures comply with IATA Regulations (IATA Cargo Handling Manual, Dangerous Goods Regulations, ULD Regulations, Temperature Control Regulations, Live Animals Regulations and Perishable Cargo Regulations). […]
Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic
Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced that it has entered into a Master Services Agreement with Aronnax, Inc. for its HT-KIT cancer therapeutic. HT-KIT research, which was conducted at NC State University to evaluate the efficacy of HT-KIT in cancerous and non-cancerous cells, has demonstrated that HT-KIT effectively kills human mast cells that […]
Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program
Bridge Biotherapeutics, a clinical-stage biotech company announced that it has entered into a joint research agreement with HitGen Inc., a Chinese drug discovery platform company. This collaboration builds on successful initial hit finding and identification work from HitGen’s DNA-encoded library (DEL), aiming to further develop the novel hits as promising drug candidates for cancer. Bridge […]
Bora Completes Acquisition of US Sterile Fill/Finish Facility From Emergent
Bora Pharmaceuticals Co., Ltd., a a global leader in pharmaceutical manufacturing announced that it has completed the acquisition from Emergent BioSolutions of its sterile manufacturing facility in Baltimore-Camden, Maryland. The facility adds drug product fill/finish to Bora’s extensive biologics drug substance capabilities. The newly acquired 87,000-sq. ft. facility provides drug product manufacturing services for sterile […]
PCI Pharma Services Successfully Completes International Inspection of New Hampshire Campus
PCI Pharma Services, a Philadelphia-based contract development and manufacturing organization (CDMO), announced in a press release on Aug. 21, 2024 that its Bedford, NH campus successfully completed the multi-agency inspection process of the International Coalition of Medicines Regulatory Authorities (ICMRA), making PCI the first drug CDMO to navigate this particular facet of ICMRA’s new Collaborative […]
